Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort

Lupus Science and Medicine

Volumn 3, Issue 1, 2016, Pages

  Urowitz, M B ^a   Gladman, D D ^a   Anderson, N M ^a   Su, J ^a   Romero Diaz, J ^b   Bae, S C ^c   Fortin, P R ^d   Sanchez Guerrero, J ^a   Clarke, A ^e   Bernatsky, S ^f   Gordon, C ^g   Hanly, J G ^h   Wallace, D J ⁱ   Isenberg, D ^j   Rahman, A ^j   Merrill, J ^k   Ginzler, E ^l   Alarcon G S ^m   Fessler, B F ^m   Petri, M ⁿ   Bruce, I N ^o,p   Khamashta, M ^q   Aranow, C ^r   Dooley, M ^s   Manzi, S ^t   Ramsey Goldman, R ^u   Sturfelt, G ^v   Nived, O ^v   Steinsson, K ^w   Zoma, A ^x   Ruiz Irastorza, G ^y   Lim, S ^z   Kalunian, K C ^aa   Inanc M ^ab   Van Vollenhoven, R ^ac   Ramos Casals, M ^ad   Kamen, D L ^ae   Jacobsen, S ^af   Peschken, C ^ag   Askanase, A ^ah   Stoll, T ^t   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

^f MONTREAL GENERAL HOSPITAL   (Canada)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^l Downstate Health Sciences University   (United States)

^m University of Alabama at Birmingham   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF MANCHESTER   (United Kingdom)

^p MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^q ST THOMAS HOSPITAL   (United Kingdom)

^r FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^s UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^t West Penn Allegheny ^*  (Switzerland)

^u NORTHWESTERN UNIVERSITY   (United States)

^v LUND UNIVERSITY HOSPITAL   (Sweden)

^w LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^x HAIRMYRES HOSPITAL   (United Kingdom)

^y HOSPITAL DE CRUCES   (Spain)

^z EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa UNIVERSITY OF CALIFORNIA   (United States)

^ab ISTANBUL UNIVERSITY   (Turkey)

^ac KAROLINSKA INSTITUTE   (Sweden)

^ad HOSPITAL CLÍNIC   (Spain)

^ae MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^af Rigshospitalet   (Denmark)

^ag UNIVERSITY OF MANITOBA   (Canada)

^ah Department of Medicine   (United States)

more..

Author keywords

Cardiovascular Disease; Inflammation; Systemic Lupus Erythematosus

Indexed keywords

ENZYME VARIANT;

ANGIOGRAPHY; ARTICLE; BLACK PERSON; CAUCASIAN; COHORT ANALYSIS; EARLY DIAGNOSIS; ECG ABNORMALITY; ECHOCARDIOGRAPHY; EXERCISE TEST; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART INFARCTION; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 85059684243     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2015-000143     Document Type: Article

References (27)

1. Urowitz MB, Gladman DD, Tom BD, et al. Changing patterns in mortality and disease outcome for patients with systemic lupus erythematosus. J Rheumatol 2008;35:2152-8.
2. Yukovich M, Vostretsova K, Chen W, et al. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014;66:608-16.
3. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 1995;22:1259-64.
4. Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality in systemic lupus erythematosus. Am J Med 1976;60:221-5.
5. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-5.
6. Petri M, Perez-Gutthann S, Spence D, et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-19.
7. Nikpour M, Urowitz MB, Gladman DD. Epidemiology of atherosclerosis in systemic lupus erythematosus. Curr Rheumatol Rep 2009;11:248-54.
8. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
9. Gladman DD, Ang M, Su L, et al. Cardiovascular morbidity in psoriatic arthritis (PsA). Ann Rheum Dis 2009;68:1131-5.
10. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinical evident cardiovascular disease or classic cardiovascular risk factors. Arthritis Rheum 2007;57:1-74-80.
11. Pahau H, Brown MA, Paul S, et al. Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT). Arthritis Res Ther 2014;16:R85.
12. Bartels CM, Buhr KA, Goldberg JW, et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 2014;41:680-7.
13. Urowitz MB, Gladman DD. Atherosclerosis and lupus\-The SLICC study. Lupus 2007;16;925-8.
14. Urowitz MB, Gladman D, Ibañez, et al., Systemic Lupus International Collaborating Clinics (SLICC). Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus 2007;16:731-5.
15. Urowitz MB, Gladman D, Ibañez D, et al., Systemic Lupus International Collaborating Clinics (SLICC). Accumulation of coronary artery disease risk factors over three years: data from an International Inception Cohort. Arthritis Rheum 2008;59: 176-80.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
18. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
19. Chow C, Donovan L, Manuel D, et al. for the Canadian Cardiovascular Outcomes Research Team. Regional variation in self-reported heart disease prevalence in Canada. Can J Cardiol 2005;21:1265-71.
20. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:338-46.
21. Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005;31:329-54.
22. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
23. Bruce IN, Urowitz MB, Gladman DD, et al. The natural history of hypercholesterolaemia in SLE. J Rheumatol 1999;26: 2137-43.
24. Muggah E, Graves E, Bennett C, et al. Ascertainment of chronic disease using population health data: a comparison of health administrative data and patient self-report. BMC Public Health 2013:13:16.
25. Arbuckle MR, McCain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
26. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009;27:165-97.
27. Majka DS, Chang RW. Is preclinical autoimmunity benign? The case of cardiovascular disease. Rheum Dis Clin North Am 2014;40:659-68.